Zeiser, R., Youssef, S., Baker, J., Kambham, N., Steinman, L., & Negrin, R. S. (2007). Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. American Society of Hematology.

Zeiser, Robert, Sawsan Youssef, Jeanette Baker, Neeraja Kambham, Lawrence Steinman, and Robert S. Negrin. Preemptive HMG-CoA Reductase Inhibition Provides Graft-versus-host Disease Protection By Th-2 Polarization While Sparing Graft-versus-leukemia Activity. American Society of Hematology, 2007.

Zeiser, Robert, et al. Preemptive HMG-CoA Reductase Inhibition Provides Graft-versus-host Disease Protection By Th-2 Polarization While Sparing Graft-versus-leukemia Activity. American Society of Hematology, 2007.